SCHEMBL12646996

SCHEMBL12646996

FCc1ccc(CNc2ccc(Cc3c[nH]c4ncccc34)cn2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 5/20 0.78
KIT P10721 4/20 0.78
CYP2C19 P33261 5/20 0.54
CYP3A4 P08684 5/20 0.54
MET P08581 2/20 0.54
CYP2D6 P10635 1/20 0.54
GPR84 Q9NQS5 1/20 0.53
FLT3 P36888 3/20 0.52
KDR P35968 2/20 0.52
LCK P06239 1/20 0.52
PGR P06401 1/20 0.52
CHRM2 P08172 1/20 0.52
HTR1A P08908 1/20 0.52
ADRA2A P08913 1/20 0.52
PDGFRB P09619 1/20 0.52
ADORA3 P0DMS8 1/20 0.52
CHRM1 P11229 1/20 0.52
PDGFRA P16234 1/20 0.52
FLT1 P17948 1/20 0.52
DRD1 P21728 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1267073 0.91 CSF1R (0.78) CSF1RKITCYP2C19CYP3A4MET
SCHEMBL878907 0.91 CSF1R (0.78) CSF1RKITCYP2C19CYP3A4MET
SCHEMBL12926432 0.90 CSF1R (0.71) CSF1RKITCYP2C19CYP3A4MET
SCHEMBL1267837 0.89 CSF1R (0.75) CSF1RKITCYP2C19CYP3A4MET
SCHEMBL1267581 0.89 CSF1R (0.75) CSF1RKITCYP2C19CYP3A4MET
SCHEMBL19898655 0.88 CSF1R (0.74) CSF1RKITCYP2C19CYP3A4MET
SCHEMBL29431664 0.88 CSF1R (1.00) CSF1RKITCYP2C19CYP3A4MET
SCHEMBL1268018 0.88 CSF1R (1.00) CSF1RKITCYP2C19CYP3A4MET
SCHEMBL1267815 0.87 CSF1R (0.73) CSF1RKITCYP2C19CYP3A4MET
Hydrochloric Acid SCHEMBL20166201 0.87 CSF1R (0.98) CSF1RKITCYP2C19CYP3A4MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7947708-B2 Compounds modulating C-kit activity PLEXXIKON, INC. (US) 2011-05-24 US disclosed
US-20090105297-A1 Compounds Modulating C-Kit Activity PLEXXIKON INC 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105297-A1 Compounds Modulating C-Kit Activity KIT, CDC7, CDK7 CSF1R 363/4885KIT 1/4885CYP2C19 2611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.